Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01673971 · ClinicalTrials.gov registry record
Optical Tomographic Imaging of Infantile Hemangiomas
A clinical trial, sponsored by Columbia University.
- Completed
- Registry status
- 15
- Enrollment target
NCT01673971: Completed study, sponsored by Columbia University.
NCT01673971 is a clinical trial that has completed, run by Columbia University. The registered enrollment target is 15 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01673971 has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- 15 participants
- Enrollment target
Study Summary
The investigators hypothesize that there are differences between infantile hemangiomas (IH) during the proliferating and involuting phases and in response to medical treatment that can be detected by optical tomography of these hemangiomas.
Primary Outcome
Measurements of absolute total hemoglobin concentration (\[THb\]) of hemangioma and normal skin are obtained using a diffuse optical imaging device and are compared at different time points.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2012-05 |
| Est. Completion | 2018-01-01 |
What the finished NCT01673971 record still lists
NCT01673971 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 15 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01673971 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01673971 about?
NCT01673971 is a clinical study titled "Optical Tomographic Imaging of Infantile Hemangiomas". The investigators hypothesize that there are differences between infantile hemangiomas (IH) during the proliferating and involuting phases and in response to medical treatment that can be detected by optical tomography of these hemangiomas.
What is the current status of trial NCT01673971?
This trial is currently completed. The enrollment target is 15 participants. The study started on 2012-05. Estimated completion is 2018-01-01.
Who is sponsoring clinical trial NCT01673971?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia